BIOMARIN PHARMACEUTICAL INC — Form 8-K
Filed September 1, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 8/100
What the filing says
BioMarin filed an 8-K on 2026-09-01 for period ending 2026-08-31 citing only Item 8.01 (Other Events), with no material contract, transaction, or business event described in the accessible filing text. The document contains only XBRL taxonomy extensions and metadata; no dollar amounts, counterparties, dates, percentages, or share counts are disclosed.
Why this rating
Item 8.01-only 8-K with no disclosed substance; routine administrative filing with no business impact apparent.
Extracted items
See more from September 1, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.